Calysta, which produces a single-cell protein ingredient for aqua and animal feed from bacteria that consume natural gas, has completed a $39 million (£28.2m) financing round to help fund its second manufacturing facility, which will be outside Asia.

Construction has begun in China on the Calysseo joint venture facility which is expected to become the world’s first commercial-scale production facility of single-cell protein (SCP).